BINDS: Basis for supporting INnovative Drug discovery and life Science research “Find, Use and Advance Your Research”

Abstract

The BINDS program (Basis for Supporting Innovative Drug Discovery and Life Science Research), has started since April 2017 to support innovative drug discovery and life science research. The objective of this program is to link the excellent research outcome in life science to the practical application of pharmaceuticals so on in our country, by providing and sharing key technological infrastructure, including synchrotron facilities at SPring-8 and the Photon Factory, cryo-electron microscopes, chemical compound libraries, and next-generation DNA sequencers. In addition, many specialists in state-of-the art technologies in the fields of structural biology, protein production, high-throughput screening (HTS) of chemical seeds to lead compounds, structural modifications and extensions, genome analysis, and in-silico screening, will support the drug discovery and life science research of researchers who submit their proposals to members of the BINDS program.